Article

Stimulation of histone deacetylase activity by metabolites of intermediary metabolism.

From the Departments of Biological Chemistry and.
Journal of Biological Chemistry (Impact Factor: 4.6). 07/2012; 287(38):32006-16. DOI: 10.1074/jbc.M112.362467
Source: PubMed

ABSTRACT Histone deacetylases (HDACs) function in a wide range of molecular processes, including gene expression, and are of significant interest as therapeutic targets. Although their native complexes, subcellular localization, and recruitment mechanisms to chromatin have been extensively studied, much less is known about whether the enzymatic activity of non-sirtuin HDACs can be regulated by natural metabolites. Here, we show that several coenzyme A (CoA) derivatives, such as acetyl-CoA, butyryl-CoA, HMG-CoA, and malonyl-CoA, as well as NADPH but not NADP(+), NADH, or NAD(+), act as allosteric activators of recombinant HDAC1 and HDAC2 in vitro following a mixed activation kinetic. In contrast, free CoA, like unconjugated butyrate, inhibits HDAC activity in vitro. Analysis of a large number of engineered HDAC1 mutants suggests that the HDAC activity can potentially be decoupled from "activatability" by the CoA derivatives. In vivo, pharmacological inhibition of glucose-6-phosphate dehydrogenase (G6PD) to decrease NADPH levels led to significant increases in global levels of histone H3 and H4 acetylation. The similarity in structures of the identified metabolites and the exquisite selectivity of NADPH over NADP(+), NADH, and NAD(+) as an HDAC activator reveal a previously unrecognized biochemical feature of the HDAC proteins with important consequences for regulation of histone acetylation as well as the development of more specific and potent HDAC inhibitors.

0 Followers
 · 
106 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Phytanic acid is a branched fatty acid that is a metabolic intermediate of chlorophyll. In this study, the effects of phytanic acid on Histone deacetylase (Hdac) activity were examined in an in vitro enzyme assay and in neuronal Neuro2a cells. Several fatty acids have been shown to be Hdac inhibitors, but phytanic acid enhanced the enzyme activity in vitro. In Neuro2a cells, phytanic acid significantly reduced histone acetylation and induced cell death, which was inhibited by an Hdac inhibitor, sodium butyrate. Theophylline, a common Hdac activator, had a similar effect on Neuro2a cell viability, and this effect was also inhibited by sodium butyrate. Phytanic acid decreased the level of intracellular active mitochondria, while butyrate increased this level. The cytotoxic effect of phytanic acid was also abolished by a caspase-9 inhibitor. Apicidin, a Hdac2- and 3-specific inhibitor, reduced the cellular toxicity, which suggests that the toxicity of phytanic acid depends on activation of the Hdac2 and 3 subtypes. Overall, these results show that phytanic acid induces mitochondrial abnormality and cell death via activation of Hdac2, 3 in Neuro2a cells. This effect of Hdac activation by phytanic acid may produce neuronal damage in Refsum disease and other peroxisomal disorders, which is caused by accumulation of phytanic acid. Copyright © 2015 Elsevier Inc. All rights reserved.
    Neurotoxicology and Teratology 01/2015; 48. DOI:10.1016/j.ntt.2015.01.006 · 3.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abnormal degradation of matrix components due to dysregulated expression of matrix metalloproteinase (MMP)-9 in macrophages has been linked to progression of acute cerebral ischemia and atherosclerosis. We report that lithium chloride (LiCl) or CHIR99021, inhibitors of Wnt signaling pathway, enhance phosphorylation of glycogen synthase kinase-3beta and suppress lipopolysaccharide-mediated upregulation of MMP-9 expression in murine macrophage RAW264.7 cells in a dose-dependent manner. Suppression of MMP-9 expression by LiCl or CHIR99021 did not result after inhibition of kinases involved in NFκB or AP-1 family proteins, but from changes in the activity of histone deacetylases. Beneficial effects on atherosclerosis or cerebral ischemia in animal studies caused by LiCl may be in part explained by the suppression of MMP-9 gene expression.
    Cell Biology International 02/2015; 39(2). DOI:10.1002/cbin.10352 · 1.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Class IIa histone deacetylases (HDACs4, -5, -7, and -9) modulate the physiology of the human cardiovascular, musculoskeletal, nervous and immune systems. The regulatory capacity of this family of enzymes stems from their ability to shuttle between nuclear and cytoplasmic compartments in response to signal-driven post-translational modification. Here, we review the current knowledge of modifications that control spatial and temporal HDAC functions by regulating subcellular localization, transcriptional functions, and cell cycle-dependent activity, ultimately impacting on human disease. We discuss the contribution of these modifications to cardiac and vascular hypertrophy, myoblast differentiation, neuronal cell survival, and neurodegenerative disorders. Copyright © 2015, The American Society for Biochemistry and Molecular Biology.
    Molecular &amp Cellular Proteomics 01/2015; 14(3). DOI:10.1074/mcp.O114.046565 · 7.25 Impact Factor